Pharmaconex West Blog

For every obstacle that drug manufacturing companies in Nigeria overcome, multiple new ones crop up. This isn’t unexpected – with the profound impact of climate change on health in Africa, a rapidly evolving technological landscape, and the ever-present macroeconomic ebbs and flows, pharmaceutical manufacturing companies in Nigeria have to stay on their toes to leverage opportunities and circumvent challenges. 

With one of the largest and youngest populations in not just Africa but the entire world, Nigeria presents the next frontier for exponential growth in the health sector. United Nations projections estimate that, by 2050, Nigeria will be 377 million people strong. Combined with the highest GDP in Africa, it is no surprise that this economic growth is spilling over into the pharma market in Nigeria.